Company: JUPGF
Filing Date: 2025-05-02
Form Type: DRS
Source: 0001641172-25-008279
Chunk: 139

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-05-02
Form: DRS
Chunk 139
---
 discounts and commissions. The underwriters may exercise this option only to cover over-allotments, if any, made in connection with this offering. To the extent the option is exercised and the conditions of the underwriting agreement are satisfied, we will be obligated to sell to the underwriters, and the underwriters will be obligated to purchase, these additional shares of common stock. The underwriters will offer these additional shares of common stock on the same terms as those on which the other shares of common stock are being offered hereby.

Discounts, Commissions, and Representative’s Warrants

We have agreed to sell the common stock to the
underwriters at a discount equal to seven percent (7.0%) of the aggregate gross proceeds raised in this offering. We have also
agreed to (i) grant to the Representative warrants to purchase a number of shares equal to six percent (6.0%) of the total number
of shares of common stock sold in this offering at an exercise price equal to 115% of the Underwritten Offering price in this offering.
The Representative’s Warrants will be non-exercisable for six months after the date of the commencement of sales in this offering,
and will expire five (5) years after such date of the commencement of sales in this offering, in accordance with Financial Industry Regulatory
Authority (“FINRA”) Rule 5110(e)(1), as more specifically set forth in the following paragraph. The Representative’s
Warrants will contain provisions for (i) one demand registration for the shares underlying the Representative’s Warrants at our
expense for a period of five (5) years from the date of the commencement of sales in this offering, in compliance with FINRA Rules 5110(g)(8)(B)
and 5110(g)(8)(C), and (ii) unlimited piggyback registration rights for a period of five (5) years after the date of the
commencement of sales in this in this offering, at our expense, in compliance with FINRA Rule 5110(g)(8)(D). The number of shares subject
to Representative’s Warrants outstanding, and the exercise price of those securities, will be adjusted proportionately, as permitted
by FINRA Rule 5110(g)(8)(E).

The Representative’s Warrants and the shares
of common stock underlying the Representative’s Warrants have been deemed compensation by FINRA, and are therefore subject to a
180-day lock-up pursuant to FINRA Rule 5110(e)(1